Journal Title：Neuropharmacology

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).

《神經(jīng)藥理學》發(fā)表神經(jīng)科學領(lǐng)域的高質(zhì)量原創(chuàng)研究和評論文章，尤其是包含神經(jīng)藥理學內(nèi)容的文章。但是，任何神經(jīng)科學領(lǐng)域的論文都會被考慮。該期刊通常不接受臨床研究，但可能會考慮人類臨床前神經(jīng)藥理學研究。該期刊只考慮那些實驗藥物的化學結(jié)構(gòu)和成分在文獻中很容易獲得或作者在提交的稿件中披露的投稿。只有在特殊情況下，才會考慮天然產(chǎn)品，而且只有在制備方法通過科學手段明確定義的情況下才會考慮?！渡窠?jīng)藥理學》發(fā)表任何長度的文章（原創(chuàng)研究和評論）。

Neuropharmacology創(chuàng)刊于1970年，由Elsevier Ltd出版商出版，收稿方向涵蓋醫(yī)學 - 神經(jīng)科學全領(lǐng)域，此刊是該細分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細分領(lǐng)域中學術(shù)影響力較大，專業(yè)度認可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 約1.0個月 ，影響因子指數(shù)4.6，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。